TY - JOUR
T1 - Revascularization of human ovarian grafts is equally efficient from both sides of the cortex tissue
AU - Kristensen, Stine G.
AU - Olesen, Hanna Ø
AU - Zeuthen, Mette Christa
AU - Pors, Susanne E
AU - Andersen, Claus Y
AU - Mamsen, Linn S
N1 - Publisher Copyright: © 2022 The Author(s)
PY - 2022/6
Y1 - 2022/6
N2 - Research question: Does revascularization of human ovarian grafts in a mouse model occur with equal efficiency from both sides of the cortex tissue? Design: Twenty-four frozen-thawed ovarian cortex pieces from 12 women were transplanted to immunodeficient mice, for 8 days to analyse graft revascularization using immunohistochemical detection of murine CD31, or for 8 weeks to evaluate follicle density (follicles/mm 3). The CD31-positive vessel area and density were quantified using a custom-designed application. Three regions of interest (ROI) were defined in each tissue section: the cortical side, the centre and the medullary side. Vessels were subdivided into three categories according to size: microvessels (<300 µm 2), small vessels (300–1000 µm 2) and large vessels (>1000–3000 µm 2). Results: No significant difference in the mean percentage of the CD31-positive vessel area was found between the three ROI (cortical side: 3.9% ± 0.2%; centre: 3.5% ± 0.2%; medullary side: 4.0% ± 0.3%; P = 0.17), but a significantly lower density of vessels was found in the centre of the human ovarian grafts compared with the cortical and medullary sides (cortical side: 323 ± 14 vessels/mm 2; centre: 240 ± 12 vessels/mm 2; medullary side: 301 ± 18 vessels/mm 2; P < 0.001). Microvessels comprised 89–91% of all vessels in the three ROI. Follicle density in ungrafted cortex pieces was 51.8 ± 17.3 and 14.7 ± 3.7 follicles/mm 3 after 8 weeks of xenografting, resulting in a follicle survival rate of 28%. Conclusions: Host revascularization was established equally efficiently from both sides of transplanted human ovarian cortex, suggesting that transplantation techniques ensuring revascularization from both sides of the ovarian graft could potentially facilitate faster graft revascularization.
AB - Research question: Does revascularization of human ovarian grafts in a mouse model occur with equal efficiency from both sides of the cortex tissue? Design: Twenty-four frozen-thawed ovarian cortex pieces from 12 women were transplanted to immunodeficient mice, for 8 days to analyse graft revascularization using immunohistochemical detection of murine CD31, or for 8 weeks to evaluate follicle density (follicles/mm 3). The CD31-positive vessel area and density were quantified using a custom-designed application. Three regions of interest (ROI) were defined in each tissue section: the cortical side, the centre and the medullary side. Vessels were subdivided into three categories according to size: microvessels (<300 µm 2), small vessels (300–1000 µm 2) and large vessels (>1000–3000 µm 2). Results: No significant difference in the mean percentage of the CD31-positive vessel area was found between the three ROI (cortical side: 3.9% ± 0.2%; centre: 3.5% ± 0.2%; medullary side: 4.0% ± 0.3%; P = 0.17), but a significantly lower density of vessels was found in the centre of the human ovarian grafts compared with the cortical and medullary sides (cortical side: 323 ± 14 vessels/mm 2; centre: 240 ± 12 vessels/mm 2; medullary side: 301 ± 18 vessels/mm 2; P < 0.001). Microvessels comprised 89–91% of all vessels in the three ROI. Follicle density in ungrafted cortex pieces was 51.8 ± 17.3 and 14.7 ± 3.7 follicles/mm 3 after 8 weeks of xenografting, resulting in a follicle survival rate of 28%. Conclusions: Host revascularization was established equally efficiently from both sides of transplanted human ovarian cortex, suggesting that transplantation techniques ensuring revascularization from both sides of the ovarian graft could potentially facilitate faster graft revascularization.
UR - http://www.scopus.com/inward/record.url?scp=85127304527&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2022.02.009
DO - 10.1016/j.rbmo.2022.02.009
M3 - Journal article
SN - 1472-6483
VL - 44
SP - 991
EP - 994
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 6
ER -